Clinical Window International web journal for medical professionals
Menu

Functions

 

 

 

Sponsored by GE Healthcare

Clinical Window Educational Program is sponsored by GE Healthcare

 

 

 

This website is accredited by Health On the Net Foundation. Click to verify.

Clinical Window Web Journal complies with the HON code standard for trustworthy health information: verify here.

 

 

 

Critical Care

Theoretical and experimental comparison of constant inspired concentration and pulsed delivery in NO therapy

E. Heinonen - M. Högman - P. Meriläinen
Department of Medical Sciences,
Clinical Physiology, Uppsala University, 751 85 Uppsala, Sweden
Tel. + 46-18-664153 Fax + 46-18-66 41 35

Email: pekka.merilainen@datex-ohmeda.com

Received: 22 June 1999
Final revision received: 7 February 2000 Accepted: 11 February 2000
This study was performed at Uppsala University, Department of Medical Science, Clinical Physiology, Uppsala, Sweden. The study was supported by NUTEK (Swedish National Board for Industrial and Technical Development), Stockholm, Sweden, and Datex-Ohmeda AB, Stockholm, Sweden

The whole article available in PDF: 672 KB

Abstract

Objective: Inhaled NO therapy of artificially ventilated patients has been established as being based on constant inspired concentration of NO. In this study a new volumetrically controlled pulsed NO delivery mode is compared with the established concentration-based concept.

Design: To evaluate the relationship between NO delivery parameters, alveolar NO fraction, and patient uptake, a mathematical lung model was created where NO delivery can be simulated in varying ventilator settings, delivery modes, and lung properties. This model and the efficacy of pulsed delivery in inducing pulmonary capillary vasodilatation were examined experimentally.
Setting: Animal laboratory, Department of Medical Sciences, Clinical Physiology.
Subjects: The experimental study was performed with nine pigs of mixed breed weighing 25-35 kg.
Interventions: The pigs were anaesthetised and artificially ventilated. Pulmonary vasoconstriction was induced by hypoxia. NO was delivered periodically in the various delivery modes.
Measurements and results: In simulation, in all delivery modes the NO uptake was found to be dependent on the ventilator settings and the volume of the dead space. Measured from pulmonary artery pressure, the pulsed delivery was as effective in reducing the induced pulmonary vasoconstriction as the constant inspired concentration delivery. The amount of NO that could reduce the vasoconstriction back to baseline was 105 nmol * min-1. By delivering in the early part of the inspiration, ambient contamination by the exhaust gas is avoided. The expired NO values obtained in the simulation and the experiments were equal. Based on the simulation, the alveolar NO fraction and the NO uptake depend on the ventilator settings and the dead space in both volumetric- and concentration- based delivery.
Conclusions: With pulsed delivery, a therapeutic effect comparable to constant inspired concentration delivery is achieved, NO gas is used more effectively, and environmental exhausts are reduced. The theoretical model shows that the NO delivery does not predict alveolar NO fraction and the NO uptake. However, it still remains an open question if the online measurement of these parameters would provide useful information, having added value in predicting and controlling the efficacy of the NO treatment.

Key words: Nitric oxide - Pulmonary vasoconstriction Pigs - NO delivery – Hypoxia

Introduction

Nitric oxide (NO) was identified as an endotheliurn-derived relaxation factor in 1987. The smooth muscle tone of the pulmonary vessels has been shown to be influenced by continuous release of NO from the endothelium, leading to an increase in CGMP that mediates relaxation. The NO administered by inhalation acts as replacement of the locally decreased NO production. Arising from this finding, inhaled NO has been used to reduce pulmonary hypertension, improve oxygenation, and lessen the right ventricular loading in patients with severe acute lung diseases.

In artificial ventilation NO has mostly been administered by constant inspired NO concentration. The possibility of a delivery concept based on the NO volume has also been discussed. However, the relation between the inspired NO concentration or amount and the alveolar NO partial pressure and the NO uptake in various ventilator settings and patient physiology has not been studied analytically before.

To exert a vasodilatory effect, the NO molecules are transported from the alveolar space into the vascular smooth muscle by diffusion. According to Fick's first law of diffusion the flux is proportional to the partial pressure gradient. Since the NO is rapidly metabolised, the blood concentration is zero. Therefore, alveolar partial pressure of NO, the NO diffusing capacity alveolar partial pressure of NO, and the NO diffusing capacity control the NO transport.

Due to high diffusing capacity, 95-100% of the NO is taken up from the alveoli meaning that thus almost all the NO exhaust is coming from the dead space. NO delivery in pulses of known amounts synchronously with the inspiration makes it possible to avoid the anatomic dead space administration and reduce the environmental exhausts. Pulsed delivery mode has been used for the treatment of persistent pulmonary hyper- tension in spontaneously breathing patients.

This study presents a model to predict the relationship of the administered NO to alveolar NO fraction, NO uptake and, further, to exhaled NO fraction. In an experimental part of this study a new delivery device for pulsed administration was tested. The efficacy of various pulsing schemes, including one equivalent to the constant concentration mode, was investigated. The differences in the safety aspects, including the rebound effect, between various NO administration modes will also be discussed. To confirm the theoretical model the measured exhaled NO fractions in different delivery settings will be compared to the predicted ones.

Published by permission of Springer-Verlag, to see the original article from the Intensive Care Medicine click here:
Intensive Care Med (2000) 26: 1116-1123


Last updated: 1 April 2002Created
Legal notice © GE Healthcare 2008
ISSN 1795-6269 (Web)
ISSN 1795-6277 (CD)
Webmaster